Kepos Capital LP Transcode Therapeutics, Inc. Transaction History

Kepos Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.2 - $3.03 $330,000 - $833,250	-275,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.03 - $3.01 $50,749 - $75,250	-25,000 Reduced 8.33%	275,000 $792,000
Q3 2021 Nov 12, 2021	BUY	$2.37 - $6.45 $711,000 - $1.94 Million	300,000 New	300,000 $897,000

6.5K

Ticker RNAZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,977,200
Market Cap $7.4M
Description
TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs incl...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.